Management of Shock in Mitral Stenosis

Initial Assessment and Stabilization

The European Society of Cardiology recommends performing urgent echocardiography to assess valve severity, ventricular function, and rule out mechanical complications such as severe mitral regurgitation or tamponade 1
Correct any reversible causes including hypovolemia, drug-induced hypotension, or arrhythmias before escalating therapy, as suggested by the European Heart Journal 1
Establish invasive arterial blood pressure monitoring for accurate hemodynamic assessment, according to the European Heart Journal 1

The European Heart Journal suggests cautious volume loading only if evidence of hypovolemia and no signs of congestion 1
Avoid aggressive fluid resuscitation as it can precipitate pulmonary edema in the setting of fixed diastolic obstruction, as stated by the European Heart Journal 1
If pulmonary congestion develops, administer oxygen to maintain saturation >90%, consider morphine for dyspnea, and initiate diuretics, as recommended by the American Heart Association, through Circulation 3, 4, 1

The American College of Cardiology recommends initiating dobutamine 5-20 mcg/kg/min as the preferred inotrope to improve cardiac output without excessive tachycardia, through the Journal of the American College of Cardiology 5, 6
Add norepinephrine if systolic blood pressure remains <90 mmHg despite dobutamine, as it is the first-line vasopressor for maintaining adequate mean arterial pressure, according to the American College of Cardiology, through Praxis Medical Insights 7

Immediately correct bradycardia or tachyarrhythmias that contribute to hemodynamic instability, as suggested by the American Heart Association, through Circulation 3, 4
If atrial fibrillation with rapid ventricular response develops, use beta-blockers or digoxin for rate control to prolong diastolic filling time, but only after hemodynamic stabilization, as recommended by the American College of Cardiology, through Praxis Medical Insights 2, 8

Consider intra-aortic balloon pump (IABP) if shock does not quickly reverse with pharmacological therapy, though evidence specific to mitral stenosis is limited, as stated by the American Heart Association, through Circulation 3, 4, 5
IABP serves as a bridge to definitive intervention rather than definitive therapy, according to the American College of Cardiology, through the Journal of the American College of Cardiology and Circulation 3, 5

Percutaneous mitral balloon commissurotomy (PMBC) is the preferred intervention for patients with favorable valve morphology, as recommended by the American College of Cardiology, through Praxis Medical Insights 2, 8
Surgical valve replacement or open commissurotomy for patients with unfavorable anatomy, according to the American College of Cardiology, through Praxis Medical Insights 8

The most dangerous error is aggressive fluid resuscitation assuming standard hypovolemic shock management—this rapidly precipitates pulmonary edema in the fixed obstruction of mitral stenosis, as stated by the European Heart Journal 1
Never use beta-blockers or calcium channel blockers acutely in the shock state despite their role in chronic mitral stenosis management, as suggested by the American Heart Association, through Circulation, and the American College of Cardiology, through the Journal of the American College of Cardiology 3, 5
Medical therapy does not prevent disease progression and shock will not resolve without addressing the valvular obstruction, as recommended by the American College of Cardiology, through Praxis Medical Insights 2
If atrial fibrillation is present, initiate anticoagulation with vitamin K antagonists (not NOACs) once hemodynamically stable, as mitral stenosis patients require warfarin specifically, according to the American College of Cardiology, through Praxis Medical Insights 2, 8